ArticleMultiple sclerosis journal - experimental, translational and clinical

Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis.

Jiwon Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.